Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 100 shares at $9.00 ($900) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Open-market purchase of $900 SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |